Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00970541 · ClinicalTrials.gov registry record · Phase 1
Effect of Cinnamon Extract on Insulin Resistance in Polycystic Ovary Syndrome
A Phase 1 study, sponsored by Pennington Biomedical Research Center.
- Terminated
- Registry status
- Phase 1
- Development phase
- 8
- Enrollment target
NCT00970541: Clinical Trial Phase 1 study, sponsored by Pennington Biomedical Research Center.
NCT00970541 is a Phase 1 study that was terminated before completion, run by Pennington Biomedical Research Center. The registered enrollment target is 8 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (87% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00970541, a Phase 1 study, was terminated before completion, sponsored by Pennington Biomedical Research Center.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 8 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether Cinnamon from the Cassae Plant is effective in the body as insulin could lower blood sugar levels.
Interventions
- DIETARY_SUPPLEMENT Cinnamon Supplementation
- DIETARY_SUPPLEMENT Placebo (wheat flour)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2009-08 |
| Est. Completion | 2013-06 |
| Phase | Phase 1 |
Why NCT00970541 stopped before completion
NCT00970541 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (87% lower).
The record links to 0 conditions, and to 2 interventions - of which Cinnamon Supplementation is the first listed.
NCT00970541 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00970541 about?
NCT00970541 is a clinical study titled "Effect of Cinnamon Extract on Insulin Resistance in Polycystic Ovary Syndrome". The purpose of this study is to determine whether Cinnamon from the Cassae Plant is effective in the body as insulin could lower blood sugar levels.
What is the current status of trial NCT00970541?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 8 participants. The study started on 2009-08. Estimated completion is 2013-06.
What interventions are being tested in trial NCT00970541?
The interventions under investigation include: Cinnamon Supplementation (DIETARY_SUPPLEMENT), Placebo (wheat flour) (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00970541?
This trial is sponsored by Pennington Biomedical Research Center, which has 258 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00970541's enrollment target sits among peer trials
8 1959th of 2000 higher than 29 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia